2022
Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter‐Defibrillator Generator Changes
Bilchick KC, Wang Y, Curtis JP, Shadman R, Dardas TF, Anand I, Lund LH, Dahlström U, Sartipy U, Levy WC. Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter‐Defibrillator Generator Changes. Journal Of The American Heart Association 2022, 11: e023743. PMID: 35766293, PMCID: PMC9333379, DOI: 10.1161/jaha.121.023743.Peer-Reviewed Original ResearchConceptsSeattle Heart Failure ModelHeart failure modelHeart failure patientsResynchronization therapyGenerator changeSurvival benefitWorse survivalFailure patientsNational Cardiovascular Data Registry ICD RegistryGC survivalSurvival Benefit AssociatedPrimary prevention indicationVentricular ejection fractionAnnual mortalityICD therapyConclusions PatientsPrevention indicationEjection fractionICD RegistryImproved survivalPrimary preventionPatient deathGreater effect sizeLVEFPatients
2013
Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR®
RUSSO AM, WANG Y, AL‐KHATIB S, CURTIS JP, LAMPERT R. Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR®. Pacing And Clinical Electrophysiology 2013, 36: 1522-1531. PMID: 23981009, DOI: 10.1111/pace.12248.Peer-Reviewed Original ResearchConceptsHospital adverse eventsDFT testingAdverse eventsImplantable cardioverter-defibrillator insertionLeft ventricular ejection fractionCardiac resynchronization therapy devicesPrimary prevention indicationVentricular ejection fractionResynchronization therapy devicesProspective randomized dataImplantable cardioverter defibrillator (ICD) technologyDefibrillation threshold testingPatterns of practiceMore comorbiditiesPrevention indicationDefibrillator insertionEjection fractionHeart failureAtrial arrhythmiasDefibrillation testingIndependent associationProcedural characteristicsTeaching hospitalDefibrillator technologyImplant procedure
2010
Prevalence and Predictors of Off-Label Use of Cardiac Resynchronization Therapy in Patients Enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry
Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR, Registry C. Prevalence and Predictors of Off-Label Use of Cardiac Resynchronization Therapy in Patients Enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. Journal Of The American College Of Cardiology 2010, 56: 766-773. PMID: 20797489, PMCID: PMC2958057, DOI: 10.1016/j.jacc.2010.05.025.Peer-Reviewed Original ResearchConceptsNew York Heart Association functional classYork Heart Association functional classQRS interval durationLabel useConsensus guidelinesMultivariable hierarchical logistic regression modelsPrevious percutaneous coronary interventionAtrial fibrillation/flutterEvidence-based consensus guidelinesFunctional classGuideline-based indicationsPrimary prevention indicationCardiac resynchronization therapyPercutaneous coronary interventionOff-label useHierarchical logistic regression modelsInterval durationLogistic regression modelsStudy time frameApplication of CRTCoronary interventionPrevention indicationDiabetes mellitusEjection fractionResynchronization therapy